Back to Results
First PageMeta Content
Europe / Government / Berlin / Jerini / Geography of Europe


Microsoft Word - Mitteilung_Eternygen_Dr. Zahn 130905_Eng.
Add to Reading List

Document Date: 2015-04-25 19:38:01

Open Document

File Size: 124,90 KB

Share Result on Facebook

City

Berlin / /

Company

IBB Beteiligungsgesellschaft mbH / ipal GmbH / Investitionsbank / Eternygen GmbH / Jerini AG / Biotech Company / /

Country

Germany / /

Currency

EUR / /

/

Event

Employment Change / /

Facility

Humboldt University / Charité University Hospital / /

/

IndustryTerm

venture capital / creative and technology‐orientated / early life science technologies / technology commercialization / pharmaceutical research / technology development / pharmaceutical / /

MedicalCondition

metabolic diseases / dietary‐related metabolic diseases / inflammatory disease / /

Organization

European Fund for Regional Development / Humboldt University Berlin / Charité University Hospital in Berlin / /

Person

Grit Zahn / /

/

Position

Head of Research Berlin / Director of Lead Discovery Biology / market leader / Head of Research / /

Product

Tivoli iPAL Radio / /

Technology

early life science technologies / molecular evolution / /

URL

www.ibb‐bet.de / /

SocialTag